The Lancet Rheumatology
@thelancetrheum.bsky.social
The #LancetRheumatology is a clinical #rheumatology journal publishing innovative & practice-changing research & opinion across all #rheumatic & #MSK disorders.
🌐 https://www.thelancet.com/journals/lanrhe/home
🌐 https://www.thelancet.com/journals/lanrhe/home
Pinned
Our November issue is live!
Including research on hip #osteoarthritis, #JIA, #BackPain, and #PsoriaticArthritis, plus much more! thelancet.com/journals/lan...
Cover by Sara Gironi Carnevale #Medsky #Rheumsky
Including research on hip #osteoarthritis, #JIA, #BackPain, and #PsoriaticArthritis, plus much more! thelancet.com/journals/lan...
Cover by Sara Gironi Carnevale #Medsky #Rheumsky
NEW—Pan American League of Associations for Rheumatology recommendations for the management of rheumatoid arthritis bit.ly/47WEe8q @panlar.bsky.social @lancetrh-americ.bsky.social
Free to read with registration on lancet.com
Free to read with registration on lancet.com
November 13, 2025 at 3:00 PM
NEW—Pan American League of Associations for Rheumatology recommendations for the management of rheumatoid arthritis bit.ly/47WEe8q @panlar.bsky.social @lancetrh-americ.bsky.social
Free to read with registration on lancet.com
Free to read with registration on lancet.com
NEW COMMENT—Revisiting safety and refining benefit of rituximab–belimumab combination for refractory #SLE bit.ly/4hWxegq #Medsky #Rheumsky
Revisiting safety and refining benefit of rituximab–belimumab combination for refractory SLE
B-cell depletion using rituximab is used to treat systemic lupus erythematosus (SLE),
particularly for patients whose disease is refractory to conventional immunosuppressants
(eg, mycophenolate), and ...
bit.ly
November 12, 2025 at 9:38 AM
NEW COMMENT—Revisiting safety and refining benefit of rituximab–belimumab combination for refractory #SLE bit.ly/4hWxegq #Medsky #Rheumsky
NEW RESEARCH—IgG4-related disease in the Japanese population: a whole-genome sequencing study bit.ly/4oVaGPm
Plus, linked Comment bit.ly/4hOOOmz
#Medsky #Rheumsky
Plus, linked Comment bit.ly/4hOOOmz
#Medsky #Rheumsky
November 6, 2025 at 3:42 PM
NEW RESEARCH—IgG4-related disease in the Japanese population: a whole-genome sequencing study bit.ly/4oVaGPm
Plus, linked Comment bit.ly/4hOOOmz
#Medsky #Rheumsky
Plus, linked Comment bit.ly/4hOOOmz
#Medsky #Rheumsky
Reposted by The Lancet Rheumatology
Our December issue is out now at www.thelancet.com/journals/lan...
Content includes diet in GI disorders; IBS; IBD; oesophageal cancer; alcohol-related liver disease; MASLD + more!
#GastroSky #LiverSky #MedSky
Content includes diet in GI disorders; IBS; IBD; oesophageal cancer; alcohol-related liver disease; MASLD + more!
#GastroSky #LiverSky #MedSky
November 6, 2025 at 6:57 AM
Our December issue is out now at www.thelancet.com/journals/lan...
Content includes diet in GI disorders; IBS; IBD; oesophageal cancer; alcohol-related liver disease; MASLD + more!
#GastroSky #LiverSky #MedSky
Content includes diet in GI disorders; IBS; IBD; oesophageal cancer; alcohol-related liver disease; MASLD + more!
#GastroSky #LiverSky #MedSky
Reposted by The Lancet Rheumatology
👉 Register now: hubs.li/Q03NdTNP0
📆 Nov 20, 2025 | 2pm GMT / 9am EST / 10pm CST
Join our expert panel as they explore innate immunity’s role in neurological diseases, and therapies to prevent inflammation-driven neurodegeneration.
#neurology #brainhealth #lancetwebinar
📆 Nov 20, 2025 | 2pm GMT / 9am EST / 10pm CST
Join our expert panel as they explore innate immunity’s role in neurological diseases, and therapies to prevent inflammation-driven neurodegeneration.
#neurology #brainhealth #lancetwebinar
November 5, 2025 at 7:50 AM
👉 Register now: hubs.li/Q03NdTNP0
📆 Nov 20, 2025 | 2pm GMT / 9am EST / 10pm CST
Join our expert panel as they explore innate immunity’s role in neurological diseases, and therapies to prevent inflammation-driven neurodegeneration.
#neurology #brainhealth #lancetwebinar
📆 Nov 20, 2025 | 2pm GMT / 9am EST / 10pm CST
Join our expert panel as they explore innate immunity’s role in neurological diseases, and therapies to prevent inflammation-driven neurodegeneration.
#neurology #brainhealth #lancetwebinar
NEW in @thelancet.com—Efficacy and safety of nipocalimab in patients with moderate-to-severe Sjögren's disease (DAHLIAS): a randomised, phase 2, placebo-controlled, double-blind trial bit.ly/47CKHoN
Plus, linked Comment bit.ly/4oJVcgV
#Medsky #Rheumsky
Plus, linked Comment bit.ly/4oJVcgV
#Medsky #Rheumsky
October 31, 2025 at 9:55 AM
NEW in @thelancet.com—Efficacy and safety of nipocalimab in patients with moderate-to-severe Sjögren's disease (DAHLIAS): a randomised, phase 2, placebo-controlled, double-blind trial bit.ly/47CKHoN
Plus, linked Comment bit.ly/4oJVcgV
#Medsky #Rheumsky
Plus, linked Comment bit.ly/4oJVcgV
#Medsky #Rheumsky
🔥Hot off the press for #ACR25 🔥
Fetal and maternal outcome in the pregnancies of patients with systemic sclerosis and very early diagnosis of systemic sclerosis in France: a prospective study bit.ly/3J5WHHm
Plus, linked Comment bit.ly/4300NHF
#Medsky #Rheumsky
Fetal and maternal outcome in the pregnancies of patients with systemic sclerosis and very early diagnosis of systemic sclerosis in France: a prospective study bit.ly/3J5WHHm
Plus, linked Comment bit.ly/4300NHF
#Medsky #Rheumsky
October 29, 2025 at 12:50 PM
🔥Hot off the press for #ACR25 🔥
Fetal and maternal outcome in the pregnancies of patients with systemic sclerosis and very early diagnosis of systemic sclerosis in France: a prospective study bit.ly/3J5WHHm
Plus, linked Comment bit.ly/4300NHF
#Medsky #Rheumsky
Fetal and maternal outcome in the pregnancies of patients with systemic sclerosis and very early diagnosis of systemic sclerosis in France: a prospective study bit.ly/3J5WHHm
Plus, linked Comment bit.ly/4300NHF
#Medsky #Rheumsky
NEW RESEARCH—Risk factors for interstitial lung disease in early rheumatoid arthritis and external validation of screening strategies: a cross-sectional analysis of the prospective SAIL-RA cohort in the USA bit.ly/3L1F0t5 @jeffsparks.bsky.social
October 27, 2025 at 2:38 PM
NEW RESEARCH—Risk factors for interstitial lung disease in early rheumatoid arthritis and external validation of screening strategies: a cross-sectional analysis of the prospective SAIL-RA cohort in the USA bit.ly/3L1F0t5 @jeffsparks.bsky.social
Reposted by The Lancet Rheumatology
Severe #glucocorticoid-induced #osteoporosis requires a long-term sequential treatment approach consisting of a bone anabolic agent followed by an antiresorptive drug www.thelancet.com/journals/lan...
#OpenAccess
#MedSky #EndoSky #RheumSky
#OpenAccess
#MedSky #EndoSky #RheumSky
October 24, 2025 at 3:08 PM
Severe #glucocorticoid-induced #osteoporosis requires a long-term sequential treatment approach consisting of a bone anabolic agent followed by an antiresorptive drug www.thelancet.com/journals/lan...
#OpenAccess
#MedSky #EndoSky #RheumSky
#OpenAccess
#MedSky #EndoSky #RheumSky
Attending #ACR25? Sophie Woolven, Deputy Editor, invites you to reach out with enquiries.
Explore our scope, reach & impact, commitment to publishing excellence, & more: hubs.li/Q03BLchR0 #Medsky #Rheumsky
Explore our scope, reach & impact, commitment to publishing excellence, & more: hubs.li/Q03BLchR0 #Medsky #Rheumsky
October 24, 2025 at 3:47 PM
Attending #ACR25? Sophie Woolven, Deputy Editor, invites you to reach out with enquiries.
Explore our scope, reach & impact, commitment to publishing excellence, & more: hubs.li/Q03BLchR0 #Medsky #Rheumsky
Explore our scope, reach & impact, commitment to publishing excellence, & more: hubs.li/Q03BLchR0 #Medsky #Rheumsky
NEW—The Nobel celebrates tolerance
News story by Heather Van Epps bit.ly/47FqW0Y #Medsky #Rheumsky @nobelprize.bsky.social
News story by Heather Van Epps bit.ly/47FqW0Y #Medsky #Rheumsky @nobelprize.bsky.social
October 24, 2025 at 10:01 AM
NEW—The Nobel celebrates tolerance
News story by Heather Van Epps bit.ly/47FqW0Y #Medsky #Rheumsky @nobelprize.bsky.social
News story by Heather Van Epps bit.ly/47FqW0Y #Medsky #Rheumsky @nobelprize.bsky.social
October 23, 2025 at 8:40 AM
Our November issue is live!
Including research on hip #osteoarthritis, #JIA, #BackPain, and #PsoriaticArthritis, plus much more! thelancet.com/journals/lan...
Cover by Sara Gironi Carnevale #Medsky #Rheumsky
Including research on hip #osteoarthritis, #JIA, #BackPain, and #PsoriaticArthritis, plus much more! thelancet.com/journals/lan...
Cover by Sara Gironi Carnevale #Medsky #Rheumsky
October 21, 2025 at 4:39 PM
Our November issue is live!
Including research on hip #osteoarthritis, #JIA, #BackPain, and #PsoriaticArthritis, plus much more! thelancet.com/journals/lan...
Cover by Sara Gironi Carnevale #Medsky #Rheumsky
Including research on hip #osteoarthritis, #JIA, #BackPain, and #PsoriaticArthritis, plus much more! thelancet.com/journals/lan...
Cover by Sara Gironi Carnevale #Medsky #Rheumsky
Attending #ACR25? Sophie Woolven, Deputy Editor, invites you to reach out with enquiries.
Explore our scope, reach & impact, commitment to publishing excellence, & more: hubs.li/Q03BLchR0
Explore our scope, reach & impact, commitment to publishing excellence, & more: hubs.li/Q03BLchR0
October 20, 2025 at 10:36 AM
Attending #ACR25? Sophie Woolven, Deputy Editor, invites you to reach out with enquiries.
Explore our scope, reach & impact, commitment to publishing excellence, & more: hubs.li/Q03BLchR0
Explore our scope, reach & impact, commitment to publishing excellence, & more: hubs.li/Q03BLchR0
Reposted by The Lancet Rheumatology
Want to stay up to date with the latest original research, perspectives and insights in your field? 🏥
Explore our Specialty Collections to stay informed with the most current and relevant content published across The Lancet Group.
🔗 thelancet.com/collections
Explore our Specialty Collections to stay informed with the most current and relevant content published across The Lancet Group.
🔗 thelancet.com/collections
October 6, 2025 at 9:08 AM
Want to stay up to date with the latest original research, perspectives and insights in your field? 🏥
Explore our Specialty Collections to stay informed with the most current and relevant content published across The Lancet Group.
🔗 thelancet.com/collections
Explore our Specialty Collections to stay informed with the most current and relevant content published across The Lancet Group.
🔗 thelancet.com/collections
ICYMI
NEW—Unscientific vaccine policy endangers vulnerable patients
Read our latest editorial bit.ly/3HWybYD #Medsky #Rheumsky
Read our latest editorial bit.ly/3HWybYD #Medsky #Rheumsky
October 6, 2025 at 1:28 PM
ICYMI
NEW REVIEW—Synovial immunopathology in psoriatic arthritis: cellular and molecular insights bit.ly/4pKi9Su #Medsky #Rheumsky
October 3, 2025 at 4:37 PM
NEW REVIEW—Synovial immunopathology in psoriatic arthritis: cellular and molecular insights bit.ly/4pKi9Su #Medsky #Rheumsky
NEW RESEARCH—Machine learning to classify the focus score and Sjögren's disease using digitalised salivary gland biopsies: a retrospective cohort study bit.ly/3W2mXVX #Medsky #Rheumsky
Machine learning to classify the focus score and Sjögren's disease using digitalised salivary gland biopsies: a retrospective cohort study
This study showed that deep learning can reliably classify the focus score and Sjögren's
disease using minor salivary gland biopsy exclusively. The study identified that CD8+
T-cell infiltration in ac...
bit.ly
September 30, 2025 at 1:28 PM
NEW RESEARCH—Machine learning to classify the focus score and Sjögren's disease using digitalised salivary gland biopsies: a retrospective cohort study bit.ly/3W2mXVX #Medsky #Rheumsky
NEW podcast episode🎧
Deputy Editor, Sophie Woolven, talks to @ScottUhlrich about personalised gait retraining for knee #osteoarthritis
Apple: bit.ly/3VBBXcZ
Spotify: bit.ly/47W9TbI
Full Article: bit.ly/4nk2rfd
#Medsky #Rheumsky #Biomechsky
Deputy Editor, Sophie Woolven, talks to @ScottUhlrich about personalised gait retraining for knee #osteoarthritis
Apple: bit.ly/3VBBXcZ
Spotify: bit.ly/47W9TbI
Full Article: bit.ly/4nk2rfd
#Medsky #Rheumsky #Biomechsky
September 26, 2025 at 10:39 AM
NEW podcast episode🎧
Deputy Editor, Sophie Woolven, talks to @ScottUhlrich about personalised gait retraining for knee #osteoarthritis
Apple: bit.ly/3VBBXcZ
Spotify: bit.ly/47W9TbI
Full Article: bit.ly/4nk2rfd
#Medsky #Rheumsky #Biomechsky
Deputy Editor, Sophie Woolven, talks to @ScottUhlrich about personalised gait retraining for knee #osteoarthritis
Apple: bit.ly/3VBBXcZ
Spotify: bit.ly/47W9TbI
Full Article: bit.ly/4nk2rfd
#Medsky #Rheumsky #Biomechsky
Reposted by The Lancet Rheumatology
Join Zoë Mullan and other Lancet Group editors to learn more about the SAGER guidelines for sex- and gender-based analyses, explore real research examples, and gain practical tips for responding to the guidelines.
📅 21 October, 2pm BST
👉 Register: hubs.li/Q03FQ_6l0
📅 21 October, 2pm BST
👉 Register: hubs.li/Q03FQ_6l0
September 23, 2025 at 8:33 AM
Join Zoë Mullan and other Lancet Group editors to learn more about the SAGER guidelines for sex- and gender-based analyses, explore real research examples, and gain practical tips for responding to the guidelines.
📅 21 October, 2pm BST
👉 Register: hubs.li/Q03FQ_6l0
📅 21 October, 2pm BST
👉 Register: hubs.li/Q03FQ_6l0
Our October issue is live!
Including research on #vaccination in #rheumatoidarthritis and
#hydroxychloroquine during #pregnancy, two Reviews on #VEXAS, plus much more! thelancet.com/journals/lan...
Cover by Sara Gironi Carnevale #Medsky #Rheumsky
Including research on #vaccination in #rheumatoidarthritis and
#hydroxychloroquine during #pregnancy, two Reviews on #VEXAS, plus much more! thelancet.com/journals/lan...
Cover by Sara Gironi Carnevale #Medsky #Rheumsky
September 23, 2025 at 11:20 AM
Our October issue is live!
Including research on #vaccination in #rheumatoidarthritis and
#hydroxychloroquine during #pregnancy, two Reviews on #VEXAS, plus much more! thelancet.com/journals/lan...
Cover by Sara Gironi Carnevale #Medsky #Rheumsky
Including research on #vaccination in #rheumatoidarthritis and
#hydroxychloroquine during #pregnancy, two Reviews on #VEXAS, plus much more! thelancet.com/journals/lan...
Cover by Sara Gironi Carnevale #Medsky #Rheumsky
NEW RESEARCH—The global, regional, and national burden attributable to low bone mineral density, 1990–2020: an analysis of a modifiable risk factor from the Global Burden of Disease Study 2021 bit.ly/4mhrbDx #Medsky #Rheumsky #GBDStudy @ihmeuw.bsky.social
September 17, 2025 at 3:27 PM
NEW RESEARCH—The global, regional, and national burden attributable to low bone mineral density, 1990–2020: an analysis of a modifiable risk factor from the Global Burden of Disease Study 2021 bit.ly/4mhrbDx #Medsky #Rheumsky #GBDStudy @ihmeuw.bsky.social
NEW—Unscientific vaccine policy endangers vulnerable patients
Read our latest editorial bit.ly/3HWybYD #Medsky #Rheumsky
Read our latest editorial bit.ly/3HWybYD #Medsky #Rheumsky
September 13, 2025 at 4:14 PM
NEW—Unscientific vaccine policy endangers vulnerable patients
Read our latest editorial bit.ly/3HWybYD #Medsky #Rheumsky
Read our latest editorial bit.ly/3HWybYD #Medsky #Rheumsky
Reposted by The Lancet Rheumatology
Our inaugural issue is out now! 🎉
Explore and download our first issue and read featured content, Editor's picks, announcements, and much more on our journal homepage: hubs.li/Q03GFPRK0
Thank you to our authors and reviewers!
#medsky #physician-researcher #obgynsky #womenshealthsky
Explore and download our first issue and read featured content, Editor's picks, announcements, and much more on our journal homepage: hubs.li/Q03GFPRK0
Thank you to our authors and reviewers!
#medsky #physician-researcher #obgynsky #womenshealthsky
September 11, 2025 at 2:41 PM
Our inaugural issue is out now! 🎉
Explore and download our first issue and read featured content, Editor's picks, announcements, and much more on our journal homepage: hubs.li/Q03GFPRK0
Thank you to our authors and reviewers!
#medsky #physician-researcher #obgynsky #womenshealthsky
Explore and download our first issue and read featured content, Editor's picks, announcements, and much more on our journal homepage: hubs.li/Q03GFPRK0
Thank you to our authors and reviewers!
#medsky #physician-researcher #obgynsky #womenshealthsky
NEW RESEARCH—Development and validation of a prognostic model for predicting the risk of allopurinol-induced severe cutaneous adverse reactions: a retrospective new-user cohort study using linked primary care, hospitalisation, and mortality data bit.ly/4mc76P1 #Medsky #Rheumsky
September 11, 2025 at 3:47 PM
NEW RESEARCH—Development and validation of a prognostic model for predicting the risk of allopurinol-induced severe cutaneous adverse reactions: a retrospective new-user cohort study using linked primary care, hospitalisation, and mortality data bit.ly/4mc76P1 #Medsky #Rheumsky